Lyell Immunopharma, Inc. Common Stock (LYEL) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for LYEL. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 84 institutions reported holding LYEL, with 12.7 million shares worth $178.0 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Arch Venture Management | 3,247,162 | $46M | UNCHANGED |
| Gsk | 1,512,659 | $21M | UNCHANGED |
| Vanguard | 976,925 | $14M | INCREASED |
| Orland Properties | 754,698 | $11M | UNCHANGED |
| BlackRock | 724,342 | $10M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Lyell Immunopharma, Inc. Common Stock on SentiSense.